Improving Access to Essential Medicines and Basic Technologies for Non-communicable Diseases
Access to medicines and technologies for non-communicable diseases is poor in low and middle-income countries. Building on the Swiss comparative advantage (broader access engagement as a country with a big pharma sector), the program addresses all components of the comprehensive framework for access to drugs, ranging from research and innovation to dispensing and use. It will also set up a dedicated global collaborative network for advocacy, information and innovation.
| Country/region | Topic | Period | Budget |
|---|---|---|---|
|
Global |
Health
Primary health care
Health systems strengthening |
01.11.2019
- 31.12.2031 |
CHF 18'000'000
|
- Other Swiss academic and research institutions
-
Sector according to the OECD Developement Assistance Commitiee categorisation HEALTH
HEALTH
Sub-Sector according to the OECD Developement Assistance Commitiee categorisation Basic health care
Health policy and administrative management
Cross-cutting topics The project also supports partner organisation improvements
Aid Type Project and programme contribution
Project number 7F10189
| Directorate/federal office responsible |
SDC |
| Credit area |
Development cooperation |
| Project partners |
Contract partner Swiss Academic and Research Institution |
| Budget | Current phase Swiss budget CHF 18'000'000 Swiss disbursement to date CHF 0 |
| Project phases | Phase 99 01.11.2019 - 31.12.2031 (Current phase) |